跳至主要内容
临床试验/CTRI/2024/11/077229
CTRI/2024/11/077229尚未招募不适用

A randomized open label controlled clinical study; to evaluate the efficacy of vrundatriphaladi ghanvati as adjuvant therapy in prameha with special reference to type 2 diabetes Mellitus.

R A Podar Medical College Ayu1 个研究点 分布在 1 个国家目标入组 119 人开始时间: 2024年11月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
119
试验地点
1
主要终点
Fasting BSL,Post prandial BSL,Hba1c and hs-crp(inflammatory parameter).

研究概览

简要总结

This study is a randomized open label controlled clinical study, to evaluate the efficacy of vrundatriphaladi ghanvati as adjuvant therapy  for 12 weeks in 119 patient with prameha (type 2 diabetes mellitus). The primary outcome will be F - BSL , PP-BSL, Hba1c and  hs-crp from base line to 12 weeks . secondary outcome will be on symptoms score of prameha at 12 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • patient having classical sign and symptoms of prameha.
  • BSL 126 to 250 mg or BSL PP gretar than 200mg to 300 or Hba1c gretar than 6.5 to 9 percentage or random BSL gretar than 200 mg.

排除标准

  • Acute medical and surgical illness IDMM diabetes ketoacidosis gestational diabetes drug induced diabetes pregnant and lactating women impaired renal function.

结局指标

主要结局

Fasting BSL,Post prandial BSL,Hba1c and hs-crp(inflammatory parameter).

时间窗: 12 weeks

次要结局

  • on symptoms score of prameha at 12 weeks(on changes in lipid profile and BMI from baseline to 12 weeks in prameha.)

研究者

发起方
R A Podar Medical College Ayu
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Vinayak Pache

Government Ayurvedic College Dharashiviv.

研究点 (1)

Loading locations...

相似试验